You have 9 free searches left this month | for more free features.

metered dose inhaler

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Asthma Trial in Saskatoon (salbutamol aqueous solution, salbutamol pressurized metered dose inhaler, )

Not yet recruiting
  • Asthma
  • salbutamol aqueous solution
  • +2 more
  • Saskatoon, Saskatchewan, Canada
    Asthma Research Lab University of Saskatchewan Room 346 Ellis Ha
Jul 26, 2023

Asthma, Patient Education Trial in Gaziantep (Demonstration method for the use of the Metered Dose Inhaler, Video watching

Not yet recruiting
  • Asthma
  • Patient Education
  • Demonstration method for the use of the Metered Dose Inhaler
  • Video watching method for the use of the Metered Dose Inhaler
  • Gaziantep, Turkey
    Hasan Kalyoncu University
Dec 6, 2022

COPD Trial in London, Wythenshawe (Part A: RPL554, Placebos, Part B: RPL554)

Completed
  • COPD
  • Part A: RPL554
  • +2 more
  • London, United Kingdom
  • +1 more
Aug 29, 2022

Asthma Trial in Spartanburg (Fluticasone propionate pressurized metered dose inhaler, Flovent HFA pressurized metered dose

Completed
  • Asthma
  • Fluticasone propionate pressurized metered dose inhaler
  • +2 more
  • Spartanburg, South Carolina
    Site 1
Aug 31, 2021

Bronchial Asthma Trial in Chandigarh (Single Inhalation technique, Tidal inhalation technique)

Recruiting
  • Bronchial Asthma
  • Single Inhalation technique
  • Tidal inhalation technique
  • Chandigarh, India
  • +1 more
Jun 23, 2022

Asthma Trial (SCH 32088 mometasone furoate (MF) metered-dose inhaler, Placebo metered-dose inhaler BID)

Withdrawn
  • Asthma
  • SCH 32088 mometasone furoate (MF) metered-dose inhaler
  • Placebo metered-dose inhaler BID
  • (no location specified)
Feb 7, 2022

Asthma Trial in United States (Albuterol dry powder inhaler, Albuterol HFA MDI (hydrofluoroalkane metered dose inhaler))

Completed
  • Asthma
  • Albuterol dry powder inhaler
  • Albuterol HFA MDI (hydrofluoroalkane metered dose inhaler)
  • Los Angeles, California
  • +8 more
Jan 18, 2022

Symptom and Quality of Life in COPD by

Recruiting
  • Pulmonary Disease, Chronic Obstructive
    • Nagoya, Aichi, Japan
    • +16 more
    Jan 17, 2023

    Asthma Trial in Worldwide (BFF MDI 160/9.6 µg BID (320/19.2µg/day), BD MDI 160 µg BID (320 µg/day))

    Recruiting
    • Asthma
    • BFF MDI 160/9.6 μg BID (320/19.2μg/day)
    • BD MDI 160 μg BID (320 μg/day)
    • Huntington Beach, California
    • +52 more
    Mar 9, 2023

    Asthma Trial (Mometasone Furoate/Formoterol Fumarate (MF/F) 100/5 mcg MDI, Mometasone Furoate/Formoterol Fumarate (MF/F) 200/5

    Completed
    • Asthma
    • Mometasone Furoate/Formoterol Fumarate (MF/F) 100/5 mcg MDI
    • Mometasone Furoate/Formoterol Fumarate (MF/F) 200/5 mcg MDI
    • (no location specified)
    Feb 7, 2022

    Exercise Induced Bronchospasm Trial in United States (Budesonide/albuterol sulfate metered-dose inhaler 160/180 µg, Placebo

    Completed
    • Exercise Induced Bronchospasm
    • Budesonide/albuterol sulfate metered-dose inhaler 160/180 μg
    • Placebo metered-dose inhaler
    • Denver, Colorado
    • +5 more
    Jan 4, 2022

    Pharmacokinetics Trial in San Antonio (Beclomethasone dipropionate BAI, Beclomethasone dipropionate MDI)

    Completed
    • Pharmacokinetics
    • Beclomethasone dipropionate BAI
    • Beclomethasone dipropionate MDI
    • San Antonio, Texas
      Teva Investigational Site
    Nov 5, 2021

    Real-world, 52-week Prospective Study to Capture Reasons for

    Not yet recruiting
    • Pulmonary Disease, Chronic Obstructive (COPD)
    • Budesonide Glycopyrronium bromide Formoterol fumarate pressurized Metered Dose Inhaler
    • (no location specified)
    Jun 13, 2023

    COPD Trial in Batman, Mersin (VIDEO-TRAINING-SESSION ABOUT MDI USE)

    Completed
    • Chronic Obstructive Pulmonary Disease
    • VIDEO-TRAINING-SESSION ABOUT MDI USE
    • Batman, Turkey
    • +1 more
    Sep 7, 2021

    Asthma, COPD Trial (SCH No. 418131 (Mometasone Furoate/Formoterol Furoate abbreviated MF/F ))

    Completed
    • Asthma
    • COPD
    • SCH No. 418131 (Mometasone Furoate/Formoterol Furoate abbreviated MF/F )
    • (no location specified)
    Feb 7, 2022

    Asthma Trial (Mometasone furoate/formoterol (MF/F) MDI, Fluticasone propionate/salmeterol (F/SC) DPI)

    Completed
    • Asthma
    • Mometasone furoate/formoterol (MF/F) MDI
    • Fluticasone propionate/salmeterol (F/SC) DPI
    • (no location specified)
    Feb 7, 2022

    Mucociliary Clearance Trial in United States (HFO MDI, HFA MDI)

    Not yet recruiting
    • Mucociliary Clearance
    • HFO MDI
    • HFA MDI
    • San Diego, California
    • +4 more
    Feb 23, 2023

    Asthma Trial (MF/F Metered Dose Inhaler (MDI) 25/5 mcg, MF/F MDI 50/5 mcg, MF/F MDI 100/5 mcg)

    Withdrawn
    • Asthma
    • MF/F Metered Dose Inhaler (MDI) 25/5 mcg
    • +6 more
    • (no location specified)
    Feb 7, 2022

    Mild Persistent Asthma Trial in London (BDP/formoterol, Placebo)

    Completed
    • Mild Persistent Asthma
    • London, United Kingdom
      Respiratory Clinical Trials - Heart Lung Centre - Queen Anne Str
    Oct 28, 2021

    Asthma Trial in Denver (Qvar, Flovent Diskus)

    Terminated
    • Asthma
    • Denver, Colorado
      National Jewish Medical and Research Center
    Nov 19, 2021

    Asthma, COPD Trial in London (Therapeutic Dose 1, Therapeutic Dose 2, Supra-therapeutic Dose)

    Completed
    • Asthma
    • Chronic Obstructive Pulmonary Disease
    • Therapeutic Dose 1
    • +3 more
    • London, Tooting, United Kingdom
      Richmond Pharmacology Ltd
    Oct 15, 2021

    Asthma, Asthma in Children Trial in Coleraine, Derry / Londonderry (aflo™ digital respiratory management platform, Standard

    Recruiting
    • Asthma
    • Asthma in Children
    • aflo™ digital respiratory management platform
    • Standard care
    • Coleraine, N.Ireland, United Kingdom
    • +1 more
    Feb 14, 2023

    COVID-19 Trial in Buffalo (Ciclesonide, Placebo)

    Completed
    • COVID-19
    • Buffalo, New York
      University of Buffalo
    Jan 6, 2022

    COPD Trial in Manchester (CHF 1535 NEXThaler 800/48, CHF 1535 NEXThaler 200/12, CHF 1535 NEXThaler PLACEBO)

    Completed
    • COPD
    • CHF 1535 NEXThaler 800/48
    • +4 more
    • Manchester, United Kingdom
      Medicine Evaluation Unit
    Oct 28, 2021